Press Release
Nicox Announces NCX 470 NDA in China Accepted for Review
  • Acceptance of the NCX 470 dossier initiates the review process
  • Regulatory decision expected within 12-18 months from the August submission
  • Q&A on Ocumension available on Nicox’s website

September 11, 2026 – release at 7:30 am CET
Sophia Antipolis, France

Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that its exclusive licensee in China, Ocumension Therapeutics, has received confirmation from China’s National Medical Products Administration (NMPA) that the NCX 470 (also referred to as OT-301 by Ocumension) New Drug Application (NDA) in China has been accepted for review. This acceptance initiates the review of the NDA by the NMPA. Nicox had previously announced the submission of the NCX 470 NDA in China as a treatment to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

“The acceptance for review of the NCX 470 NDA in China initiates the examination process and is another key step towards its commercialisation in this territory. We look forward to continuing to work with the Ocumension team as they prepare for a future launch.” said Gavin Spencer, Chief Executive Officer of Nicox.

Ocumension’s Press release is here.

Ocumension has paid Nicox license fees of €18 million for the rights to develop and commercialise NCX 470 in the Chinese, Korean and Southeast Asian markets, contributed 50% of the Denali clinical trial costs and is one of Nicox’s principal shareholders. Nicox will receive tiered royalties on sales of NCX 470 made by Ocumension ranging from 6% to 12%. Ocumension already has an ophthalmology sales force in place throughout China and is therefore well-positioned for a rapid launch of NCX 470.

There is no fixed period for approval of a pharmaceutical product in China, however the review process typically takes 12 to 18 months following submission. The decision on NCX 470 in China is expected after the decision by the U.S. FDA, who have assigned the PDUFA date1 for 30 April 2027.  

Key Upcoming NCX 470 Milestones

  • Japan Phase 3 clinical trials results: trials ongoing  
  • NDA approval in the U.S.: PDUFA date 30 April 2027
  • U.S. Launch: expected in H2 2027, subject to NDA approval
  • NDA decision in China: Submission made in August 2026, accepted for review on 10 September 2026
About NCX 470
NCX 470 is a novel nitric oxide (NO)-donating bimatoprost eye drop that leverages the potent intraocular pressure (IOP)-lowering effects of NO and prostaglandin analogs (PGAs). NCX 470 incorporates Nicox’s proprietary NO-donating research platform and bimatoprost in a single molecule. NCX 470 is designed to release bimatoprost and NO into the eye to lower IOP by two different pathways in patients with open-angle glaucoma or ocular hypertension. NO is a well-known small, naturally occurring signalling molecule that plays a key role in the regulation of IOP through activation of soluble guanylate cyclase (sGC). NO brings additional IOP-lowering efficacy by enhancing aqueous humor drainage from the eye via a different mechanism of action to that of PGAs.

NCX 470 has completed two Phase 3 clinical trials designed to fulfil the regulatory requirements for safety and efficacy to support NDA submissions in the U.S. and China, Mont Blanc and Denali. Both trials were positive and met the efficacy endpoints necessary for submission of a New Drug Application in the United States and China. NDAs for NCX 470 have been submitted in the U.S. and China. NCX 470 is an investigational product and has not yet been approved by the FDA.

About Nicox

Nicox SA is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. Nicox’s lead late-stage development program is NCX 470 (bimatoprost grenod), a novel nitric oxide-donating bimatoprost eye drop, for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, licensed to Ocumension Therapeutics for the Chinese, Korean and Southeast Asian markets and to Kowa in the rest of the world.  Nicox also has a preclinical research program on NCX 1728, a nitric oxide-donating phosphodiesterase-5 inhibitor, with Glaukos. Nicox’s first product, VYZULTA® in glaucoma, licensed exclusively worldwide to Bausch + Lomb, is available commercially in the U.S. and over 15 other territories. Nicox generates revenue from ZERVIATE® in allergic conjunctivitis, licensed in multiple geographies, including to Harrow, Inc. in the U.S., and Ocumension Therapeutics in the Chinese and in the majority of Southeast Asian markets.

Nicox, headquartered in Sophia Antipolis, France, is listed on Euronext Growth Paris (Ticker symbol: ALCOX).

For more information www.nicox.com

Analyst coverage
H.C. Wainwright & Co        Yi Chen           New York, U.S.  
The views expressed by analysts in their coverage of Nicox are those of the author and do not reflect the views of Nicox. Additionally, the information contained in their reports may not be correct or current. Nicox disavows any obligation to correct or to update the information contained in analyst reports.

Contacts  
Nicox
Gavin Spencer
Chief Executive Officer
T +33 (0)4 97 24 53 00
communications@nicox.com
 
Disclaimer
The information contained in this document may be modified without prior notice. This information includes forward-looking statements. Such forward-looking statements are not guarantees of future performance. These statements are based on current expectations or beliefs of the management of Nicox S.A. and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Nicox S.A. and its affiliates, directors, officers, employees, advisers or agents, do not undertake, nor do they have any obligation, to provide updates or to revise any forward-looking statements.

Risks factors which are likely to have a material effect on Nicox’s business are presented in section 3 of the “Rapport Annuel 2025” which are available on Nicox’s website (www.nicox.com).

Finally, this press release may be drafted in the French and English languages. If both versions are interpreted differently, the French language version shall prevail.

Nicox S.A.
Sundesk Sophia Antipolis, Bâtiment C, Emerald Square, Rue Evariste Galois, 06410 Biot, France
T +33 (0)4 97 24 53 00


1 A PDUFA date is the target date by which the U.S. Food and Drug Administration (FDA) aims to complete its review and issue a decision on a New Drug Application (NDA) under the Prescription Drug User Fee Act (PDUFA).

Attachment

Lille (France), Cambridge (Massachusetts, United States), September 11, 2026 – GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announces that following the annual review of the Euronext Paris indices, the Scientific Council of the Indices has decided to admit GENFIT to the CAC Mid 60 and SBF 120 indices.

These changes will become effective after the market closes on Friday, September 18, 2026.

Pascal Prigent, CEO of GENFIT, commented: “We are pleased to be added to the Euronext CAC Mid 60 and SBF 120 indices. This inclusion comes after a positive momentum for GENFIT and growing investor confidence in our strategy and our ability to execute on it. This milestone further validates our continued commitment to bringing innovative therapies and diagnostic solutions to patients with rare and life-threatening liver diseases while creating long-term value for our shareholders.”

The CAC Mid 60 and SBF 120 are among the most widely-followed indices on Euronext Paris, representing mid-sized listed companies and a broader selection of 120 major securities, respectively. The company’s admission to the SBF 120 reflects its increased market capitalization, liquidity and visibility. It is expected to enhance the company’s profile among institutional investors and confirms its growing relevance within the French equity market.

END

ABOUT GENFIT

GENFIT is a biopharmaceutical company committed to improving the lives of patients with rare, life-threatening liver diseases whose medical needs remain largely unmet. GENFIT is a pioneer in liver disease research and development with a rich history and a solid scientific heritage spanning more than two decades. Today, GENFIT focuses on Acute on-chronic Liver Failure (ACLF) and associated conditions such as acute decompensation (AD) and hepatic encephalopathy (HE). It develops therapeutic assets which have complementary mechanisms of action, selected to address key pathophysiological pathways. GENFIT also targets other serious diseases, such as cholangiocarcinoma (CCA), urea cycle disorders (UCD) and organic acidemia (OA). Its R&D portfolio, covering several stages of development, ensures a constant news flow. GENFIT’s expertise in developing high-potential molecules – from early to advanced pre-commercialization stages – culminated in 2024 with the accelerated approval of Iqirvo® (elafibranor) by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom for second-line treatment of Primary Biliary Cholangitis (PBC). Iqirvo® is now marketed in several countries.1   Beyond therapies, GENFIT also has a diagnostic franchise including NIS2+® for the detection of Metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH for non-alcoholic steatohepatitis). GENFIT, a BCorp™ certified company since 2025, is headquartered in Lille, France and has offices in Paris (France) and Cambridge, MA (USA). The Company is listed on the Euronext regulated market in Paris, Compartment B (Euronext: GNFT). In 2021, Ipsen became one of GENFIT’s largest shareholders, acquiring an 8% stake in the Company’s capital. www.genfit.com

FORWARD LOOKING STATEMENTS

This press release contains certain forward-looking statements with respect to GENFIT, including, but not limited to, statements regarding the expected benefits of GENFIT’s inclusion in the CAC Mid 60 and SBF 120 indices, investor interest in the Company, the Company’s strategic positioning, its ability to execute on its strategy, its future growth prospects, the advancement of its pipeline and the creation of long-term value for shareholders. The use of certain words, such as “believe”, “potential”, “expect”, “target”, “may”, “will”, “should”, “could”, “if” and similar expressions, is intended to identify forward-looking statements. Although the Company believes its expectations are based on the current expectations and reasonable assumptions of the Company’s management, these forward-looking statements are subject to numerous known and unknown risks and uncertainties, which could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. Inclusion in stock market indices does not guarantee increased liquidity, sustained investor interest, share price appreciation or future operating performance. These risks and uncertainties include, among others, the uncertainties inherent in research and development, including in relation to non-clinical and pre-clinical programs, reproducibility of preclinical results, the translation of animal model data to human biology, in relation to safety of drug candidates, cost of, progression of, and results from, our ongoing and planned clinical trials, patient recruitment, review and approvals by regulatory authorities in the United States, Europe and worldwide, of our drug and diagnostic candidates, pricing, approval and commercial success of elafibranor in the relevant jurisdictions, exchange rate fluctuations, and our continued ability to raise capital to fund our development, as well as those risks and uncertainties discussed or identified in the Company’s public filings with the AMF, including those listed in Chapter 2 “Risk Factors and Internal Control” of the Company’s 2025 Universal Registration Document filed on April 3, 2026 (no. 26-0221) with the Autorité des marchés financiers (“AMF”), which is available on GENFIT’s website (www.genfit.fr) and the AMF’s website (www.amf.org), and those discussed in reports filed with the AMF or otherwise made public, by the Company. In addition, even if the results, performance, financial position and liquidity of the Company and the development of the industry in which it operates are consistent with such forward-looking statements, they may not be predictive of results or developments in future periods. These forward-looking statements speak only as of the date of publication of this press release. Other than as required by applicable law, the Company does not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise.

CONTACTS

GENFIT | Investors

Jean-Christophe Marcoux – Chief Corporate Affairs Officer | Tel: +33 3 2016 4000 |
jean-christophe.marcoux@genfit.com

Kevin Gardner – Life Science Advisors | kgardner@lifesciadvisors.com

GENFIT | Media

Bruno ARABIAN – Agence Maarc | Tel : 06 87 88 47 26 | bruno.arabian@maarc.fr

Stephanie Boyer – Press relations | Tel: +333 2016 4000 | stephanie.boyer@genfit.com

GENFIT | 885 Avenue Eugène Avinée, 59120 Loos – FRANCE | +333 2016 4000 | www.genfit.com 


1 Elafibranor is marketed and commercialized, notably in the U.S and Europe, by Ipsen under the trademark Iqirvo®

Attachment

NOTICE

Elis announces the early redemption on 13 October 2026 of its €380,000,000 2.25% bonds convertible into new shares and/or exchangeable for existing shares
due 2029 (OCEANEs)
ISIN FR001400AFJ9 (the “Bonds”)

Puteaux, September 11, 2026 – Elis (the “Company”) informs the holders of the Bonds (the “Bondholders”) that it will proceed with the early redemption on 13 October 2026 (the “Early Redemption Date”) of all Bonds outstanding on such date, pursuant to the first paragraph of Condition 1.10.1.3, “Early redemption at the Company’s option”, of the terms and conditions of the Bonds dated 22 September 2022 (the “Terms and Conditions”).

Capitalised terms that are not otherwise defined in this notice shall have the meanings given to them in the Terms and Conditions.

Unless the Bondholders exercise their Conversion/Exchange Right in accordance with the Terms and Conditions, the Company will redeem in cash on the Early Redemption Date each Bond outstanding on such date at a price per Bond equal to EUR 100,129.45 (the “Early Redemption Price”), being the par value of each Bond (EUR 100,000) together with EUR 129.45 in accrued interest calculated from (and including) 22 September 2026 to (but excluding) the Early Redemption Date.

In accordance with the first paragraph of Condition 1.10.1.3 of the Terms and Conditions, at the Company’s request, Conv-Ex Advisors Limited, acting as Calculation Agent in respect of the Bonds, has verified that the arithmetic mean, calculated over a period of 20 consecutive Trading Days from (and including) 11 August 2026 to (and including) 7 September 2026, selected by the Company from among the 40 consecutive Trading Days from (and including) 17 July 2026 to (and including) 10 September 2026, of the products, in respect of each such Trading Day, of (i) the Volume-Weighted Average Price of the Shares on that Trading Day and (ii) the Conversion/Exchange Ratio applicable on that Trading Day, exceeded 130% of the par value of each Bond.

In accordance with Conditions 1.10.1.3 and 2.3 of the Terms and Conditions, a Bondholder may exercise its Conversion/Exchange Right in respect of any Bond held by it, provided that the relevant Request Date in respect of such exercise falls no later than 2 October 2026 (being the seventh (7th) Business Day preceding the Early Redemption Date), and that such exercise is otherwise made in accordance with the Terms and Conditions.

Bondholders wishing to exercise their Conversion/Exchange Right should contact the financial intermediary holding their Bonds in a securities account sufficiently in advance so that all requirements for a valid exercise, including receipt of the exercise request and transfer of the corresponding Bonds, are completed by the applicable deadline. The centralising agent for the Bonds is Uptevia, Cœur Défense Tour A – 90-110 Esplanade du Général de Gaulle 92400 Courbevoie (the “Centralising Agent”).

Each Bond in respect of which the Conversion/Exchange Right has not been validly exercised by the applicable deadline will be redeemed in cash at the Early Redemption Price on the Early Redemption Date.

As of the date of this notice, 3,800 Bonds remain outstanding out of a total of 3,800 Bonds initially issued. The Conversion/Exchange Ratio is currently equal to 6,256.8564 Shares per Bond. Assuming that all Bondholders exercise their Conversion/Exchange Right, a maximum of 23,776,054 Elis shares could be delivered, representing approximately 10.21% of the Company’s current share capital, subject to any subsequent adjustment of the Conversion/Exchange Ratio in accordance with the Terms and Conditions. The Company intends to use the existing Shares it holds following the completion of its share buyback program on 9 July 2026, thereby limiting the number of newly issued Shares that may be required. Bondholders validly exercising their Conversion/Exchange Right may receive newly issued Shares and/or existing Shares, as determined by the Company. Settlement and delivery of Shares will occur in accordance with the Terms and Conditions and the instructions of the Centralising Agent.

IMPORTANT NOTICE

The early redemption of the Bonds may not be accepted in any jurisdiction where such redemption would be prohibited or restricted by applicable law, or by residents of any such jurisdiction. No document relating to the exercise of the early redemption option may be transmitted, directly or indirectly, in or into any such jurisdiction or to any such person.

This notice does not constitute an offer to sell, a solicitation of an offer to purchase, or an offer to purchase any securities of Elis in any jurisdiction.

Contacts

Nicolas Buron
Director of Investor Relations, Financing & Treasury
Phone: + 33 (0)1 75 49 98 30 – nicolas.buron@elis.com

Charline Lefaucheux
Investor Relations
Phone: + 33 (0)1 75 49 98 15 – charline.lefaucheux@elis.com

Attachment

Ageas completes the sale of its 30.95% stake in Maybank Ageas Holdings Berhad to Maybank

Ageas announces today the completion of the sale of its 30.95% stake in the share capital of Maybank Ageas Holdings Berhad (MAHB) to Maybank for a total cash consideration equivalent to EUR 1.1 billion1.

The transaction generates a net capital gain after tax of EUR 464 million. The agreement values 100% of MAHB at EUR 3.5 billion, implying a price-to-book (P/B) ratio of about 2x the 2025 IFRS Equity.

The completion of the transaction allows Ageas to realise the significant value created through its more than 25-year partnership with Maybank. The transaction further demonstrates the value-creating potential of Ageas’s partnership model and enhances the Group’s financial flexibility.

The transaction is solvency accretive, adding 23pp to the Solvency II ratio. 

Ageas sincerely thanks Maybank’s management and all Etiqa employees for their collaboration throughout our partnership and wishes the company continued success in the years ahead. 

Ageas is a Belgian rooted listed international insurance Group with a heritage spanning 200 years. It offers Retail and Business customers Life and Non-Life insurance products designed to suit their specific needs, today and tomorrow, and is also engaged in reinsurance activities. As one of Europe’s larger insurance companies, Ageas concentrates its activities in Europe and Asia, which together make up the major part of the global insurance market. It operates successful insurance businesses in Belgium, the UK, Portugal, Türkiye, China, India, Thailand, Vietnam, Laos, Cambodia and the Philippines through a combination of wholly owned subsidiaries and long-term partnerships with strong financial institutions and key distributors. Ageas ranks among the market leaders in the countries in which it operates. It represents a staff force of about 53,000 people and reported annual inflows of EUR 19.6 billion in 2025.


1 Including a EUR 53 million pre-completion dividend.

Attachment

AUCKLAND, New Zealand, Sept. 11, 2026 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space systems, today launched its 16th Electron rocket of the year with a dedicated mission for a confidential customer.

The “Happily Ever Faster” mission lifted off from Rocket Lab Launch Complex 1 in New Zealand at 3:28 p.m. NZST on 11 September and successfully deployed a single Earth observation satellite to a 500km circular low Earth orbit.

“Happily Ever Faster” is Rocket Lab’s 16th launch of the year and 95th launch overall. Rocket Lab’s next Electron launch is scheduled to take place from Launch Complex 1 for another commercial constellation operator before the end of the month. As global launch availability continues to strain the market, Electron’s regular and reliable launch cadence provides schedule certainty and dedicated access to space for satellite operators of the industry’s next-generation constellations.

Rocket Lab Media Contact
Murielle Baker
media@rocketlabusa.com

About Rocket Lab
Rocket Lab (Nasdaq: RKLB) is an end-to-end space company delivering rockets, satellites, and spacecraft components for commercial, government, and defense missions. Driven by its industry-leading small-lift rockets Electron and HASTE and its upcoming reusable Neutron medium-lift rocket, Rocket Lab delivers reliable and responsive launch for the world’s most important missions from constellation deployment to missile defense. Rocket Lab’s satellites and components have powered more than 1,700 missions in Earth orbit, as well as deep-space exploration of the Moon, Mars, and beyond. Learn more at www.rocketlabcorp.com.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development, operational expansion and business strategy, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at https://investors.rocketlabcorp.com which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

COLUMBIA, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) — Tenable Holdings, Inc. (Nasdaq: TENB) (“Tenable”), the exposure management company, announced today the pricing of $725.0 million aggregate principal amount of 0.25% Convertible Senior Notes due 2031 (the “notes”) in a private placement (the “offering”) only to persons reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering was upsized from the previously announced offering size of $650.0 million aggregate principal amount of the notes. Tenable has also granted the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $75.0 million aggregate principal amount of the notes. The sale of the notes to the initial purchasers is expected to close on September 15, 2026, subject to customary closing conditions.

The notes will be general senior unsecured obligations of Tenable. The notes will accrue interest payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2027, at a rate of 0.25% per year. The notes will mature on September 15, 2031, unless earlier converted, redeemed or repurchased.

Tenable estimates that the net proceeds from the offering will be approximately $705.6 million (or approximately $778.8 million if the initial purchasers exercise their option to purchase additional notes in full), after deducting the initial purchasers’ discounts and estimated offering expenses. Tenable expects to use the net proceeds from the offering (i) to pay the approximately $58.1 million cost of the capped call transactions described below, (ii) to repurchase approximately $170.5 million of its common stock concurrently with the pricing of the notes as described below, (iii) to pay the cost of repaying in full the term loans under Tenable’s senior secured credit facility (the “credit facility”) and (iv) for general corporate purposes, which may include additional share repurchases, acquisitions or strategic investments in complementary businesses or technologies, working capital, operating expenses, capital expenditures and general and administrative expenses. If the initial purchasers exercise their option to purchase additional notes, Tenable expects to use a portion of the net proceeds from the sale of the additional notes to enter into additional capped call transactions, with the remainder to be used for general corporate purposes.

The notes will be convertible at the option of the holders in certain circumstances. Upon conversion, Tenable will pay cash up to the aggregate principal amount of the notes to be converted and pay or deliver, as the case may be, cash, shares of Tenable’s common stock or a combination of cash and shares of Tenable’s common stock, at Tenable’s election, in respect of the remainder, if any, of Tenable’s conversion obligation in excess of the aggregate principal amount of the notes being converted.

The conversion rate will initially be 22.3005 shares of Tenable’s common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $44.84 per share of Tenable’s common stock). The initial conversion price represents a premium of approximately 40.0% over the last reported sale price of $32.03 per share of Tenable’s common stock on September 10, 2026. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or if Tenable delivers a notice of redemption, it will, in certain circumstances, increase the conversion rate for a holder who elects to convert its notes in connection with such a corporate event or convert its notes called (or deemed called, in the case of an optional redemption) for redemption during the related redemption period, as the case may be.

Tenable may not redeem the notes prior to September 20, 2029, except in the event of a cleanup redemption described below. Tenable may redeem for cash all or any portion of the notes (subject to certain limitations), at its option, on a redemption date on or after September 20, 2029 and before the 31st scheduled trading day immediately prior to the maturity date if the last reported sale price of Tenable’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which Tenable provides the related notice of redemption at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. In addition, subject to certain conditions, Tenable may redeem for cash all, but not less than all, of the notes at any time before the 31st scheduled trading day immediately prior to the maturity date if the aggregate principal amount of the notes that remains outstanding at such time is less than $80.0 million at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.

If Tenable undergoes a “fundamental change” (as defined in the indenture that will govern the notes) then, subject to certain conditions and exceptions, holders may require Tenable to repurchase for cash all or any portion of their notes at a fundamental change repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

In connection with the pricing of the notes, Tenable entered into privately negotiated capped call transactions with certain of the initial purchasers or affiliates thereof and certain other financial institutions (the “option counterparties”). The capped call transactions cover, subject to customary adjustments substantially similar to those applicable to the notes, the number of shares of Tenable’s common stock initially underlying the notes. The capped call transactions are expected generally to reduce the potential dilution to Tenable’s common stock upon any conversion of notes and/or offset any cash payments Tenable is required to make in excess of the principal amount of converted notes, as the case may be, with such reduction and/or offset subject to a cap. If the initial purchasers exercise their option to purchase additional notes, Tenable expects to use a portion of the net proceeds from the sale of the additional notes to enter into additional capped call transactions with the option counterparties.

The cap price of the capped call transactions relating to the notes will initially be $64.06, which represents a premium of 100.0% over the last reported sale price of Tenable’s common stock on the Nasdaq Global Select Market on September 10, 2026, and is subject to certain adjustments under the terms of the capped call transactions.

In connection with establishing their initial hedges of the capped call transactions, Tenable expects that the option counterparties or their respective affiliates will purchase shares of Tenable’s common stock and/or enter into various derivative transactions with respect to Tenable’s common stock concurrently with or shortly after the pricing of the notes. This activity could increase (or reduce the size of any decrease in) the market price of Tenable’s common stock or the notes at that time.

In addition, Tenable expects that the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Tenable’s common stock and/or purchasing or selling Tenable’s common stock or other securities of Tenable in secondary market transactions following the pricing of the notes and prior to the maturity of the notes (and are likely to do so during any observation period related to a conversion of notes, following any redemption of the notes or any repurchase of the notes upon a fundamental change, or, to the extent Tenable exercises the relevant election under the capped call transactions, following any other repurchase of the notes). This activity could also cause or avoid an increase or a decrease in the market price of Tenable’s common stock or the notes, which could affect the ability of a holder of notes to convert the notes and, to the extent the activity occurs during any observation period related to a conversion of notes, it could affect the number of shares, if any, and value of the consideration that a holder of notes will receive upon conversion of the notes.

Tenable expects to use approximately $170.5 million of the net proceeds from the offering to repurchase approximately 5.3 million shares of its common stock concurrently with the pricing of the notes in privately negotiated transactions effected with or through one of the initial purchasers of the notes or its affiliate at a purchase price per share equal to the last reported sale price of Tenable’s common stock on the Nasdaq Global Select Market on September 10, 2026. These repurchases could increase (or reduce the size of any decrease in) the market price of Tenable’s common stock or the notes prior to, concurrently with or shortly after the pricing of the notes and could have resulted in a higher effective conversion price for the notes. Tenable may also conduct further repurchases of its common stock after the offering is completed pursuant to its previously authorized share repurchase program.

The notes were only offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act by means of a private offering memorandum. The notes and any shares of Tenable’s common stock issuable upon conversion of the notes have not been and will not be registered under the Securities Act, any state securities laws or the securities laws of any other jurisdiction, and unless so registered, may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.

This press release is neither an offer to sell nor a solicitation of an offer to buy any of these securities nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification thereof under the securities laws of any such state or jurisdiction.

About Tenable

Tenable is the exposure management company, exposing and closing the cybersecurity gaps that erode business value, reputation and trust. Tenable’s AI-powered exposure management platform radically unifies security visibility, insight and action across the attack surface, equipping modern organizations to protect against attacks from IT infrastructure to cloud environments to critical infrastructure and everywhere in between. By protecting enterprises from security exposure, Tenable reduces business risk for over 40,000 customers around the globe.

Forward-Looking Statements

This press release contains “forward-looking” statements, as that term is defined under the federal securities laws, including statements concerning the proposed terms of the notes and capped call transactions, the completion, timing and size of the proposed offering of the notes and capped call transactions, the anticipated use of proceeds from the offering, including the repayment of the term loans under the credit facility and Tenable’s plan to repurchase shares of outstanding common stock and the terms of any repurchase transactions, the potential impact of the foregoing or related transactions on dilution to holders of Tenable’s common stock, the market price of Tenable’s common stock or the notes or the conversion price of the notes. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond Tenable’s control. Tenable’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to whether Tenable will consummate the offering of notes on the expected terms or at all, which could differ or change based upon market conditions or for other reasons, and the other risks detailed in Tenable’s Form 10-K filed with the Securities and Exchange Commission (“SEC”) for the year ended December 31, 2025, in Tenable’s quarterly reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 and in other filings and reports that Tenable may file from time to time with the SEC. The forward-looking statements included in this press release represent Tenable’s views as of the date of this press release. Tenable anticipates that subsequent events and developments will cause Tenable’s views to change. Tenable undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Tenable’s views as of any date subsequent to the date of this press release.

Media Contact
Tenable
tenablepr@tenable.com

COLUMBIA, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) — Tenable Holdings, Inc. (Nasdaq: TENB) (“Tenable”), the exposure management company, announced today the pricing of $725.0 million aggregate principal amount of 0.25% Convertible Senior Notes due 2031 (the “notes”) in a private placement (the “offering”) only to persons reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering was upsized from the previously announced offering size of $650.0 million aggregate principal amount of the notes. Tenable has also granted the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $75.0 million aggregate principal amount of the notes. The sale of the notes to the initial purchasers is expected to close on September 15, 2026, subject to customary closing conditions.

The notes will be general senior unsecured obligations of Tenable. The notes will accrue interest payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2027, at a rate of 0.25% per year. The notes will mature on September 15, 2031, unless earlier converted, redeemed or repurchased.

Tenable estimates that the net proceeds from the offering will be approximately $705.6 million (or approximately $778.8 million if the initial purchasers exercise their option to purchase additional notes in full), after deducting the initial purchasers’ discounts and estimated offering expenses. Tenable expects to use the net proceeds from the offering (i) to pay the approximately $58.1 million cost of the capped call transactions described below, (ii) to repurchase approximately $170.5 million of its common stock concurrently with the pricing of the notes as described below, (iii) to pay the cost of repaying in full the term loans under Tenable’s senior secured credit facility (the “credit facility”) and (iv) for general corporate purposes, which may include additional share repurchases, acquisitions or strategic investments in complementary businesses or technologies, working capital, operating expenses, capital expenditures and general and administrative expenses. If the initial purchasers exercise their option to purchase additional notes, Tenable expects to use a portion of the net proceeds from the sale of the additional notes to enter into additional capped call transactions, with the remainder to be used for general corporate purposes.

The notes will be convertible at the option of the holders in certain circumstances. Upon conversion, Tenable will pay cash up to the aggregate principal amount of the notes to be converted and pay or deliver, as the case may be, cash, shares of Tenable’s common stock or a combination of cash and shares of Tenable’s common stock, at Tenable’s election, in respect of the remainder, if any, of Tenable’s conversion obligation in excess of the aggregate principal amount of the notes being converted.

The conversion rate will initially be 22.3005 shares of Tenable’s common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $44.84 per share of Tenable’s common stock). The initial conversion price represents a premium of approximately 40.0% over the last reported sale price of $32.03 per share of Tenable’s common stock on September 10, 2026. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or if Tenable delivers a notice of redemption, it will, in certain circumstances, increase the conversion rate for a holder who elects to convert its notes in connection with such a corporate event or convert its notes called (or deemed called, in the case of an optional redemption) for redemption during the related redemption period, as the case may be.

Tenable may not redeem the notes prior to September 20, 2029, except in the event of a cleanup redemption described below. Tenable may redeem for cash all or any portion of the notes (subject to certain limitations), at its option, on a redemption date on or after September 20, 2029 and before the 31st scheduled trading day immediately prior to the maturity date if the last reported sale price of Tenable’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which Tenable provides the related notice of redemption at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. In addition, subject to certain conditions, Tenable may redeem for cash all, but not less than all, of the notes at any time before the 31st scheduled trading day immediately prior to the maturity date if the aggregate principal amount of the notes that remains outstanding at such time is less than $80.0 million at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.

If Tenable undergoes a “fundamental change” (as defined in the indenture that will govern the notes) then, subject to certain conditions and exceptions, holders may require Tenable to repurchase for cash all or any portion of their notes at a fundamental change repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

In connection with the pricing of the notes, Tenable entered into privately negotiated capped call transactions with certain of the initial purchasers or affiliates thereof and certain other financial institutions (the “option counterparties”). The capped call transactions cover, subject to customary adjustments substantially similar to those applicable to the notes, the number of shares of Tenable’s common stock initially underlying the notes. The capped call transactions are expected generally to reduce the potential dilution to Tenable’s common stock upon any conversion of notes and/or offset any cash payments Tenable is required to make in excess of the principal amount of converted notes, as the case may be, with such reduction and/or offset subject to a cap. If the initial purchasers exercise their option to purchase additional notes, Tenable expects to use a portion of the net proceeds from the sale of the additional notes to enter into additional capped call transactions with the option counterparties.

The cap price of the capped call transactions relating to the notes will initially be $64.06, which represents a premium of 100.0% over the last reported sale price of Tenable’s common stock on the Nasdaq Global Select Market on September 10, 2026, and is subject to certain adjustments under the terms of the capped call transactions.

In connection with establishing their initial hedges of the capped call transactions, Tenable expects that the option counterparties or their respective affiliates will purchase shares of Tenable’s common stock and/or enter into various derivative transactions with respect to Tenable’s common stock concurrently with or shortly after the pricing of the notes. This activity could increase (or reduce the size of any decrease in) the market price of Tenable’s common stock or the notes at that time.

In addition, Tenable expects that the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Tenable’s common stock and/or purchasing or selling Tenable’s common stock or other securities of Tenable in secondary market transactions following the pricing of the notes and prior to the maturity of the notes (and are likely to do so during any observation period related to a conversion of notes, following any redemption of the notes or any repurchase of the notes upon a fundamental change, or, to the extent Tenable exercises the relevant election under the capped call transactions, following any other repurchase of the notes). This activity could also cause or avoid an increase or a decrease in the market price of Tenable’s common stock or the notes, which could affect the ability of a holder of notes to convert the notes and, to the extent the activity occurs during any observation period related to a conversion of notes, it could affect the number of shares, if any, and value of the consideration that a holder of notes will receive upon conversion of the notes.

Tenable expects to use approximately $170.5 million of the net proceeds from the offering to repurchase approximately 5.3 million shares of its common stock concurrently with the pricing of the notes in privately negotiated transactions effected with or through one of the initial purchasers of the notes or its affiliate at a purchase price per share equal to the last reported sale price of Tenable’s common stock on the Nasdaq Global Select Market on September 10, 2026. These repurchases could increase (or reduce the size of any decrease in) the market price of Tenable’s common stock or the notes prior to, concurrently with or shortly after the pricing of the notes and could have resulted in a higher effective conversion price for the notes. Tenable may also conduct further repurchases of its common stock after the offering is completed pursuant to its previously authorized share repurchase program.

The notes were only offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act by means of a private offering memorandum. The notes and any shares of Tenable’s common stock issuable upon conversion of the notes have not been and will not be registered under the Securities Act, any state securities laws or the securities laws of any other jurisdiction, and unless so registered, may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.

This press release is neither an offer to sell nor a solicitation of an offer to buy any of these securities nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification thereof under the securities laws of any such state or jurisdiction.

About Tenable

Tenable is the exposure management company, exposing and closing the cybersecurity gaps that erode business value, reputation and trust. Tenable’s AI-powered exposure management platform radically unifies security visibility, insight and action across the attack surface, equipping modern organizations to protect against attacks from IT infrastructure to cloud environments to critical infrastructure and everywhere in between. By protecting enterprises from security exposure, Tenable reduces business risk for over 40,000 customers around the globe.

Forward-Looking Statements

This press release contains “forward-looking” statements, as that term is defined under the federal securities laws, including statements concerning the proposed terms of the notes and capped call transactions, the completion, timing and size of the proposed offering of the notes and capped call transactions, the anticipated use of proceeds from the offering, including the repayment of the term loans under the credit facility and Tenable’s plan to repurchase shares of outstanding common stock and the terms of any repurchase transactions, the potential impact of the foregoing or related transactions on dilution to holders of Tenable’s common stock, the market price of Tenable’s common stock or the notes or the conversion price of the notes. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond Tenable’s control. Tenable’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to whether Tenable will consummate the offering of notes on the expected terms or at all, which could differ or change based upon market conditions or for other reasons, and the other risks detailed in Tenable’s Form 10-K filed with the Securities and Exchange Commission (“SEC”) for the year ended December 31, 2025, in Tenable’s quarterly reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 and in other filings and reports that Tenable may file from time to time with the SEC. The forward-looking statements included in this press release represent Tenable’s views as of the date of this press release. Tenable anticipates that subsequent events and developments will cause Tenable’s views to change. Tenable undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Tenable’s views as of any date subsequent to the date of this press release.

Media Contact
Tenable
tenablepr@tenable.com

With no upgrade fees, no activation fees and cash back in Verizon Dollars just for being a customer, the choice is simple

What you need to know:

  • Switch to Verizon and get the new iPhone 18 Pro now. No trade-in needed. And get the latest iPhone every year with Simplicity.
  • No activation or upgrade fees when you enroll in Verizon Loyalty.
  • Cash back in Verizon Dollars just for being a customer, plus exclusive daily drops and epic experiences with Verizon Shine.
  • Preorders for iPhone 18 Pro, iPhone 18 Pro Max, Apple Watch Series 12, Apple Watch Ultra 4 and AirPods 5 start September 12 (8am ET). iPhone Duo is available to pre-order starting on Friday, October 16.

NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) — It’s official: the new iPhone 18 Pro is coming to Verizon. With the most advanced pro camera system featuring a redesigned 48MP Fusion Main camera with variable aperture and the highest sustained performance in iPhone history powered by the latest-generation chips, there’s never been a better time to upgrade than with the iPhone 18 Pro lineup. iPhone 18 Pro Max even delivers the biggest jump in battery life ever on an iPhone, so it keeps up all day and then some.

For customers who are tired of complexity and want a simple, cost-effective plan alongside the new iPhone 18 Pro lineup, Verizon offers simple pricing, no activation or upgrade fees and a brand-new iPhone every single year. Plus, Verizon is offering the latest Apple products, including Apple Watch Series 12, Apple Watch Ultra 4, AirPods 5, and iPhone Duo—the first-ever foldable iPhone.

Simplicity moves beyond tiered network confusion and provides a simple choice for mobile service, with options to get a new phone every year with Simplicity Pro. With America’s Most Reliable 5G Network for everyone at an affordable price, including unlimited 5G Ultra Wideband data, 10GB of premium mobile hotspot and roaming in Canada and Mexico all standard. That’s it. That’s the plan.

Get iPhone 18 Pro now

  • Switch, get iPhone 18 Pro and upgrade every year: Switch to Verizon and get iPhone 18 Pro now plus the latest iPhone every year with Simplicity Pro. Enjoy zero activation or upgrade fees when enrolled in Verizon Loyalty, plus monthly cash back in Verizon Dollars and access to exclusive daily drops and epic experiences. All for $80 a month after Auto Pay and switcher discounts, plus taxes and fees.
    • Here’s how it works: Get iPhone 18 Pro today with no trade-in, and return it in good working condition to upgrade to a new model every year. Additional terms and conditions apply.
  • Save up to $1,200 with myPlan: Trade in an eligible phone and add a new line to receive up to $1,200 off a new iPhone with an eligible myPlan. Customers upgrading an existing line can get up to $1,020 off when they trade in an eligible phone on an eligible myPlan.
    • How it works: Purchase a new iPhone on a 36-month, interest-free payment plan and trade in an eligible Apple, Google, Motorola or Samsung phone that’s been active on an account for at least 60 days. Verizon covers up to $1,200 via monthly promo credits applied over 36 months. Additional terms and conditions apply.
  • Bundle an iPhone and save: Buy a new iPhone or bring your own iPhone with a new line, and get a new Apple Watch Series 12 and iPad on us.
    • How it works: Buy an eligible iPhone on Simplicity, Simplicity Plus, Pro or myPlan, or bring your own iPhone with a new line activation. Then, purchase the Apple Watch Series 12 and iPad on a 36-month interest-free payment plan and add a monthly service line for each device with Auto Pay. Verizon covers the cost of the devices by providing monthly credits over 36 months. If a customer brings their own iPhone, the new line must remain active on the account for at least six months. This offer stacks with both the Simplicity and myPLan
  • Verizon Business offers: Get iPhone 18 Pro (256GB) on us, or save up to $1,200 on iPhone 18 Pro Max.
    • How it works: For a limited time, switch to receive up to $1,200 off a new iPhone with an eligible trade-in, device payment plan and select My Biz Plan. Plus, customers can save $360 when they port in their existing number. All credits applied over 36 months.

Verizon Loyalty: The only loyalty program for ALL customers on any plan

Goodbye activation and upgrade fees: All postpaid customers on all phone and connected device plans can opt-in to Verizon’s Loyalty program and say goodbye to activation and upgrade fees—that’s up to $40 in fees per device.

Verizon Dollars: A first-of-its-kind program that rewards customers with 3% back in Verizon Dollars every single month, just for being a customer. Verizon Dollars can be redeemed for devices, accessories or up to 5x for each Verizon Dollar from top brands.

Verizon Shine, every Monday, every day, all year-round: The loyalty program that gives customers a reason to look forward to Monday, all year-round. All Verizon customers on any plan can enter weekly for a chance to win once-in-a-lifetime experiences, alongside daily drops including tickets to concerts and sporting events, exclusive merchandise, dining vouchers, gift cards and more. Opt-in into loyalty in one simple step through the My Verizon app.        

The latest iPhone models

iPhone Duo is the first foldable iPhone, featuring a breakthrough design that’s beautiful, versatile, and durable. iPhone Duo opens to a large 7.6-inch inner display for viewing content, gaming, and multitasking, and closes to a compact, pocketable 5.4-inch outer display. Built to last with an innovative hardware design and precision hinge, iPhone Duo is powered by A20 Pro to deliver pro performance and impressive all-day battery life, and offers an advanced camera system, with the folding design unlocking fun new ways to use the camera that aren’t possible on any other iPhone. iOS 27 is also reimagined for the versatile ways users can interact with iPhone Duo.

iPhone 18 Pro and iPhone 18 Pro Max offer the new 48MP Fusion Main camera with variable aperture, the most advanced camera Apple has ever made, and new Pro controls let users customize their experience. Powered by A20 Pro, iPhone 18 Pro and iPhone 18 Pro Max deliver huge leaps in battery life and performance. iPhone Duo and iPhone 18 Pro models feature Apple Intelligence1 and Siri AI2, an entirely new version of Siri, rolling out in beta in English with iOS 27, to bring AI capabilities together with a user’s personal context to become an intelligent personal hub with privacy and security at the core. iPhone Duo is available in two refined colors: star white and night sky. iPhone 18 Pro and iPhone 18 Pro Max are available in four elegant finishes: black, silver, glacier and an all-new burgundy.

iPhone Duo and iPhone 18 Pro models feature eSIM3, offering greater flexibility, better security, seamless connectivity compared to traditional physical SIM cards, and more battery life on eSIM-only models. iPhone Duo features an eSIM-only design that saves internal space to maximize battery capacity while eSIM-only models of iPhone 18 Pro and iPhone 18 Pro Max take advantage of the space formerly occupied by the physical SIM with a larger battery that provides two additional hours of video playback.

The newest Apple Watch models

Apple Watch Series 12 and Apple Watch Ultra 4 offer the most accurate heart rate sensing in a wearable4. Both new models have been engineered with the new Health Sensing System and S11 chip to offer an enhanced suite of health and fitness features including a new readiness score, higher-frequency heart rate and heart rate variability (HRV) measurements, plus extended workout battery life and faster charging. Apple Watch Series 12 is available in 42mm and 46mm sizes in an array of beautiful finishes, including dark bronze, black, light gold and space gray aluminum; radiant gold and natural titanium; and a stunning ceramic material, in pearl white and night blue. Apple Watch Ultra 4 is available in natural and black titanium.

With watchOS 27, Apple Intelligence comes to the wrist, bringing Siri AI to Apple Watch Series 12 and Apple Watch Ultra 4 with personal context understanding and broad world knowledge5. Arriving later this year, new Audio Intelligence features roll out in beta in English to help users stay aware of the world around them, catch what they missed, and remember key moments — with user control, privacy, security, and accessibility at the center of their design6 — along with a redesigned Health app on iPhone and iPad, starting in U.S. English, including a new Longevity tab with a Health Age feature showing how metrics are tracking relative to a user’s age7.

Introducing AirPods 5

AirPods 5 deliver the industry’s best Active Noise Cancellation (ANC)8 in an open-ear design, powered by a new multiport acoustic architecture and next-generation Adaptive EQ for even more immersive sound. Their breakthrough open-ear ANC removes up to 50 percent more external noise compared to the previous generation, alongside a more natural Transparency mode. Combined with Siri AI and iPhone, AirPods enable users to draw on their personal context and get answers with broad world knowledge, entirely hands-free1. Users can also respond to Siri using head gestures or use Live Translation to help connect across languages. For users who want even more, AirPods 5 with Wireless Charging Case adds longer battery life and on-stem volume control9.

Get your new iPhone at Verizon

Visit Verizon.com, the My Verizon app or your local Verizon store to preorder your iPhone 18 Pro, iPhone 18 Pro Max, Apple Watch Series 12, Apple Watch Ultra 4, and AirPods 5 starting September 12 at 8am ET, with wide availability on September 18. iPhone Duo will be available to pre-order starting on Friday, October 16. Verizon Business customers can visit the Verizon Business website or contact their account manager to order. All new iPhone models will also be available from Visible, StraightTalk, Total Wireless and Verizon Prepaid.

This announcement was originally published by Verizon. Read the original press release.

Media contact:                                               
George Koroneos
george.koroneos@verizon.com

Based on RootMetrics® U.S. RootScore® Report: 1H 2026. Not an endorsement. All rights reserved.

1. Apple Intelligence is available with Siri settings and device language set to Chinese (simplified), Chinese (traditional), Danish, Dutch, English, French, German, Italian, Japanese, Korean, Norwegian, Portuguese, Spanish, Swedish, Turkish, or Vietnamese. Some features may not be available in all regions or languages. Some devices may not be available in all regions. Siri AI is rolling out in beta with iOS 27 and requires an Apple Intelligence-enabled device set to a supported language. Available in English to start. Siri AI will not be initially available in the EU on iOS. Certain Apple Intelligence features that rely on server-side models are subject to daily usage limits, including but not limited to Siri AI, intelligent photo editing tools, Image Playground, and AFM 3 Cloud models in Shortcuts. Daily limits may vary by feature, request complexity, system demand, system policies, and other factors. Expanded access to such features will be available for a fee in the future. Use of these features is subject to Apple Intelligence terms and conditions. Learn more at apple.com/apple-intelligence. Siri AI is not available for users under 13.
2. Siri AI will not be available initially in the EU on iOS, iPadOS, and watchOS. Features that rely on Siri AI will also not be available in the EU on iOS, iPadOS, and watchOS. Apple is working hard to find a path forward that preserves its users’ privacy and security.
3. Use of an eSIM requires a carrier that supports eSIM and a wireless service plan. See carrier for details. To learn more, visit apple.com/esim.
4. Based on data from an Apple-conducted study of heart rate accuracy during July and August 2026, utilizing commercially available bestselling wearables available as of June 2026. For more information, visit apple.com/hraccuracy.
5. Apple Intelligence is available with Siri settings and device language set to Chinese (simplified), Chinese (traditional), Danish, Dutch, English, French, German, Italian, Japanese, Korean, Norwegian, Portuguese, Spanish, Swedish, Turkish, or Vietnamese. Some features may not be available in all regions or languages. Some devices may not be available in all regions. Siri AI is rolling out in beta in watchOS 27 and requires an Apple Intelligence-enabled device set to a supported language. Available in English to start. Siri AI will not be initially available in the EU on watchOS. Certain Apple Intelligence features that rely on server-side models are subject to daily usage limits, including but not limited to Siri AI. Daily limits may vary by feature, request complexity, system demand, system policies, and other factors. Expanded access to such features will be available for a fee in the future. Use of these features is subject to Apple Intelligence terms and conditions. Learn more at apple.com/apple-intelligence. Siri AI is not available to users under 13.
6. Audio Intelligence includes Live Rewind, Siri Recap, Sound Recognition, and faster Shazam and requires Apple Watch Series 12 or Apple Watch Ultra 4. Live Rewind and Siri Recap will be available in beta in late 2026 and require an Apple Intelligence-enabled iPhone 16 or later (excluding iPhone 16e). Will be available in English to start and will not initially be available in the EU. Certain Audio Intelligence features that rely on server-side models are subject to daily usage limits, including but not limited to Live Rewind and Siri Recap. For more information, visit support.apple.com/148354.
7. The redesigned Health app is available on Apple Intelligence-enabled iPhone and iPad models with the latest software, with select features available only on iPhone. Some features may not be available in all regions or languages. Health Age requires Apple Watch. The test to estimate VO2 Max requires Apple Watch, AirPods Pro 3, or a third-party heart rate sensing device. Some features require users to be 18 or older. For information on Apple Intelligence availability, visit support.apple.com/en-us/121115.
8. Testing conducted by Apple in July 2026 using AirPods 5 paired with iPhone 17 with prerelease AirPods firmware and iOS 27. Noise reduction was tested in accordance with IEC 60268-24. Comparison made against the bestselling wireless open-ear headphones commercially available at the time of testing. Performance depends on device settings, environment, and many other factors.
9. Battery life varies by use. See apple.com/batteries for details.

Verizon Communications Inc. (NYSE, Nasdaq: VZ) powers and empowers how its millions of customers live, work and play, delivering on their demand for mobility, reliable network connectivity and security. Headquartered in New York City, serving countries worldwide and nearly all of the Fortune 500, Verizon generated revenues of $134.8 billion in 2024. Verizon’s world-class team never stops innovating to meet customers where they are today and equip them for the needs of tomorrow. For more, visit verizon.com or find a retail location at verizon.com/stores.

VERIZON’S ONLINE MEDIA CENTER: News releases, stories, media contacts and other resources are available at verizon.com/news. News releases are also available through an RSS feed. To subscribe, visit www.verizon.com/about/rss-feeds/.

With no upgrade fees, no activation fees and cash back in Verizon Dollars just for being a customer, the choice is simple

What you need to know:

  • Switch to Verizon and get the new iPhone 18 Pro now. No trade-in needed. And get the latest iPhone every year with Simplicity.
  • No activation or upgrade fees when you enroll in Verizon Loyalty.
  • Cash back in Verizon Dollars just for being a customer, plus exclusive daily drops and epic experiences with Verizon Shine.
  • Preorders for iPhone 18 Pro, iPhone 18 Pro Max, Apple Watch Series 12, Apple Watch Ultra 4 and AirPods 5 start September 12 (8am ET). iPhone Duo is available to pre-order starting on Friday, October 16.

NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) — It’s official: the new iPhone 18 Pro is coming to Verizon. With the most advanced pro camera system featuring a redesigned 48MP Fusion Main camera with variable aperture and the highest sustained performance in iPhone history powered by the latest-generation chips, there’s never been a better time to upgrade than with the iPhone 18 Pro lineup. iPhone 18 Pro Max even delivers the biggest jump in battery life ever on an iPhone, so it keeps up all day and then some.

For customers who are tired of complexity and want a simple, cost-effective plan alongside the new iPhone 18 Pro lineup, Verizon offers simple pricing, no activation or upgrade fees and a brand-new iPhone every single year. Plus, Verizon is offering the latest Apple products, including Apple Watch Series 12, Apple Watch Ultra 4, AirPods 5, and iPhone Duo—the first-ever foldable iPhone.

Simplicity moves beyond tiered network confusion and provides a simple choice for mobile service, with options to get a new phone every year with Simplicity Pro. With America’s Most Reliable 5G Network for everyone at an affordable price, including unlimited 5G Ultra Wideband data, 10GB of premium mobile hotspot and roaming in Canada and Mexico all standard. That’s it. That’s the plan.

Get iPhone 18 Pro now

  • Switch, get iPhone 18 Pro and upgrade every year: Switch to Verizon and get iPhone 18 Pro now plus the latest iPhone every year with Simplicity Pro. Enjoy zero activation or upgrade fees when enrolled in Verizon Loyalty, plus monthly cash back in Verizon Dollars and access to exclusive daily drops and epic experiences. All for $80 a month after Auto Pay and switcher discounts, plus taxes and fees.
    • Here’s how it works: Get iPhone 18 Pro today with no trade-in, and return it in good working condition to upgrade to a new model every year. Additional terms and conditions apply.
  • Save up to $1,200 with myPlan: Trade in an eligible phone and add a new line to receive up to $1,200 off a new iPhone with an eligible myPlan. Customers upgrading an existing line can get up to $1,020 off when they trade in an eligible phone on an eligible myPlan.
    • How it works: Purchase a new iPhone on a 36-month, interest-free payment plan and trade in an eligible Apple, Google, Motorola or Samsung phone that’s been active on an account for at least 60 days. Verizon covers up to $1,200 via monthly promo credits applied over 36 months. Additional terms and conditions apply.
  • Bundle an iPhone and save: Buy a new iPhone or bring your own iPhone with a new line, and get a new Apple Watch Series 12 and iPad on us.
    • How it works: Buy an eligible iPhone on Simplicity, Simplicity Plus, Pro or myPlan, or bring your own iPhone with a new line activation. Then, purchase the Apple Watch Series 12 and iPad on a 36-month interest-free payment plan and add a monthly service line for each device with Auto Pay. Verizon covers the cost of the devices by providing monthly credits over 36 months. If a customer brings their own iPhone, the new line must remain active on the account for at least six months. This offer stacks with both the Simplicity and myPLan
  • Verizon Business offers: Get iPhone 18 Pro (256GB) on us, or save up to $1,200 on iPhone 18 Pro Max.
    • How it works: For a limited time, switch to receive up to $1,200 off a new iPhone with an eligible trade-in, device payment plan and select My Biz Plan. Plus, customers can save $360 when they port in their existing number. All credits applied over 36 months.

Verizon Loyalty: The only loyalty program for ALL customers on any plan

Goodbye activation and upgrade fees: All postpaid customers on all phone and connected device plans can opt-in to Verizon’s Loyalty program and say goodbye to activation and upgrade fees—that’s up to $40 in fees per device.

Verizon Dollars: A first-of-its-kind program that rewards customers with 3% back in Verizon Dollars every single month, just for being a customer. Verizon Dollars can be redeemed for devices, accessories or up to 5x for each Verizon Dollar from top brands.

Verizon Shine, every Monday, every day, all year-round: The loyalty program that gives customers a reason to look forward to Monday, all year-round. All Verizon customers on any plan can enter weekly for a chance to win once-in-a-lifetime experiences, alongside daily drops including tickets to concerts and sporting events, exclusive merchandise, dining vouchers, gift cards and more. Opt-in into loyalty in one simple step through the My Verizon app.        

The latest iPhone models

iPhone Duo is the first foldable iPhone, featuring a breakthrough design that’s beautiful, versatile, and durable. iPhone Duo opens to a large 7.6-inch inner display for viewing content, gaming, and multitasking, and closes to a compact, pocketable 5.4-inch outer display. Built to last with an innovative hardware design and precision hinge, iPhone Duo is powered by A20 Pro to deliver pro performance and impressive all-day battery life, and offers an advanced camera system, with the folding design unlocking fun new ways to use the camera that aren’t possible on any other iPhone. iOS 27 is also reimagined for the versatile ways users can interact with iPhone Duo.

iPhone 18 Pro and iPhone 18 Pro Max offer the new 48MP Fusion Main camera with variable aperture, the most advanced camera Apple has ever made, and new Pro controls let users customize their experience. Powered by A20 Pro, iPhone 18 Pro and iPhone 18 Pro Max deliver huge leaps in battery life and performance. iPhone Duo and iPhone 18 Pro models feature Apple Intelligence1 and Siri AI2, an entirely new version of Siri, rolling out in beta in English with iOS 27, to bring AI capabilities together with a user’s personal context to become an intelligent personal hub with privacy and security at the core. iPhone Duo is available in two refined colors: star white and night sky. iPhone 18 Pro and iPhone 18 Pro Max are available in four elegant finishes: black, silver, glacier and an all-new burgundy.

iPhone Duo and iPhone 18 Pro models feature eSIM3, offering greater flexibility, better security, seamless connectivity compared to traditional physical SIM cards, and more battery life on eSIM-only models. iPhone Duo features an eSIM-only design that saves internal space to maximize battery capacity while eSIM-only models of iPhone 18 Pro and iPhone 18 Pro Max take advantage of the space formerly occupied by the physical SIM with a larger battery that provides two additional hours of video playback.

The newest Apple Watch models

Apple Watch Series 12 and Apple Watch Ultra 4 offer the most accurate heart rate sensing in a wearable4. Both new models have been engineered with the new Health Sensing System and S11 chip to offer an enhanced suite of health and fitness features including a new readiness score, higher-frequency heart rate and heart rate variability (HRV) measurements, plus extended workout battery life and faster charging. Apple Watch Series 12 is available in 42mm and 46mm sizes in an array of beautiful finishes, including dark bronze, black, light gold and space gray aluminum; radiant gold and natural titanium; and a stunning ceramic material, in pearl white and night blue. Apple Watch Ultra 4 is available in natural and black titanium.

With watchOS 27, Apple Intelligence comes to the wrist, bringing Siri AI to Apple Watch Series 12 and Apple Watch Ultra 4 with personal context understanding and broad world knowledge5. Arriving later this year, new Audio Intelligence features roll out in beta in English to help users stay aware of the world around them, catch what they missed, and remember key moments — with user control, privacy, security, and accessibility at the center of their design6 — along with a redesigned Health app on iPhone and iPad, starting in U.S. English, including a new Longevity tab with a Health Age feature showing how metrics are tracking relative to a user’s age7.

Introducing AirPods 5

AirPods 5 deliver the industry’s best Active Noise Cancellation (ANC)8 in an open-ear design, powered by a new multiport acoustic architecture and next-generation Adaptive EQ for even more immersive sound. Their breakthrough open-ear ANC removes up to 50 percent more external noise compared to the previous generation, alongside a more natural Transparency mode. Combined with Siri AI and iPhone, AirPods enable users to draw on their personal context and get answers with broad world knowledge, entirely hands-free1. Users can also respond to Siri using head gestures or use Live Translation to help connect across languages. For users who want even more, AirPods 5 with Wireless Charging Case adds longer battery life and on-stem volume control9.

Get your new iPhone at Verizon

Visit Verizon.com, the My Verizon app or your local Verizon store to preorder your iPhone 18 Pro, iPhone 18 Pro Max, Apple Watch Series 12, Apple Watch Ultra 4, and AirPods 5 starting September 12 at 8am ET, with wide availability on September 18. iPhone Duo will be available to pre-order starting on Friday, October 16. Verizon Business customers can visit the Verizon Business website or contact their account manager to order. All new iPhone models will also be available from Visible, StraightTalk, Total Wireless and Verizon Prepaid.

This announcement was originally published by Verizon. Read the original press release.

Media contact:                                               
George Koroneos
george.koroneos@verizon.com

Based on RootMetrics® U.S. RootScore® Report: 1H 2026. Not an endorsement. All rights reserved.

1. Apple Intelligence is available with Siri settings and device language set to Chinese (simplified), Chinese (traditional), Danish, Dutch, English, French, German, Italian, Japanese, Korean, Norwegian, Portuguese, Spanish, Swedish, Turkish, or Vietnamese. Some features may not be available in all regions or languages. Some devices may not be available in all regions. Siri AI is rolling out in beta with iOS 27 and requires an Apple Intelligence-enabled device set to a supported language. Available in English to start. Siri AI will not be initially available in the EU on iOS. Certain Apple Intelligence features that rely on server-side models are subject to daily usage limits, including but not limited to Siri AI, intelligent photo editing tools, Image Playground, and AFM 3 Cloud models in Shortcuts. Daily limits may vary by feature, request complexity, system demand, system policies, and other factors. Expanded access to such features will be available for a fee in the future. Use of these features is subject to Apple Intelligence terms and conditions. Learn more at apple.com/apple-intelligence. Siri AI is not available for users under 13.
2. Siri AI will not be available initially in the EU on iOS, iPadOS, and watchOS. Features that rely on Siri AI will also not be available in the EU on iOS, iPadOS, and watchOS. Apple is working hard to find a path forward that preserves its users’ privacy and security.
3. Use of an eSIM requires a carrier that supports eSIM and a wireless service plan. See carrier for details. To learn more, visit apple.com/esim.
4. Based on data from an Apple-conducted study of heart rate accuracy during July and August 2026, utilizing commercially available bestselling wearables available as of June 2026. For more information, visit apple.com/hraccuracy.
5. Apple Intelligence is available with Siri settings and device language set to Chinese (simplified), Chinese (traditional), Danish, Dutch, English, French, German, Italian, Japanese, Korean, Norwegian, Portuguese, Spanish, Swedish, Turkish, or Vietnamese. Some features may not be available in all regions or languages. Some devices may not be available in all regions. Siri AI is rolling out in beta in watchOS 27 and requires an Apple Intelligence-enabled device set to a supported language. Available in English to start. Siri AI will not be initially available in the EU on watchOS. Certain Apple Intelligence features that rely on server-side models are subject to daily usage limits, including but not limited to Siri AI. Daily limits may vary by feature, request complexity, system demand, system policies, and other factors. Expanded access to such features will be available for a fee in the future. Use of these features is subject to Apple Intelligence terms and conditions. Learn more at apple.com/apple-intelligence. Siri AI is not available to users under 13.
6. Audio Intelligence includes Live Rewind, Siri Recap, Sound Recognition, and faster Shazam and requires Apple Watch Series 12 or Apple Watch Ultra 4. Live Rewind and Siri Recap will be available in beta in late 2026 and require an Apple Intelligence-enabled iPhone 16 or later (excluding iPhone 16e). Will be available in English to start and will not initially be available in the EU. Certain Audio Intelligence features that rely on server-side models are subject to daily usage limits, including but not limited to Live Rewind and Siri Recap. For more information, visit support.apple.com/148354.
7. The redesigned Health app is available on Apple Intelligence-enabled iPhone and iPad models with the latest software, with select features available only on iPhone. Some features may not be available in all regions or languages. Health Age requires Apple Watch. The test to estimate VO2 Max requires Apple Watch, AirPods Pro 3, or a third-party heart rate sensing device. Some features require users to be 18 or older. For information on Apple Intelligence availability, visit support.apple.com/en-us/121115.
8. Testing conducted by Apple in July 2026 using AirPods 5 paired with iPhone 17 with prerelease AirPods firmware and iOS 27. Noise reduction was tested in accordance with IEC 60268-24. Comparison made against the bestselling wireless open-ear headphones commercially available at the time of testing. Performance depends on device settings, environment, and many other factors.
9. Battery life varies by use. See apple.com/batteries for details.

Verizon Communications Inc. (NYSE, Nasdaq: VZ) powers and empowers how its millions of customers live, work and play, delivering on their demand for mobility, reliable network connectivity and security. Headquartered in New York City, serving countries worldwide and nearly all of the Fortune 500, Verizon generated revenues of $134.8 billion in 2024. Verizon’s world-class team never stops innovating to meet customers where they are today and equip them for the needs of tomorrow. For more, visit verizon.com or find a retail location at verizon.com/stores.

VERIZON’S ONLINE MEDIA CENTER: News releases, stories, media contacts and other resources are available at verizon.com/news. News releases are also available through an RSS feed. To subscribe, visit www.verizon.com/about/rss-feeds/.

PERTH, Australia, Sept. 10, 2026 (GLOBE NEWSWIRE) — Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKRY) (‘Alkane’ or ‘the Company’) is pleased to summarise the latest update to the Mineral Resource and Ore Reserve estimates for its assets in Australia and Sweden as at 30 June 2026.

Individual Mineral Resources and Ore Reserves Statements for Björkdal, Tomingley and Costerfield will be released simultaneously with this announcement. Complete details for each estimate, as required by the ASX Listing Rules and the JORC Code, are set out in the individual statements.

Group Measured and Indicated Mineral Resources,1

Location Tonnage (kt) Gold grade (g/t) Copper grade (%) Antimony grade (%) Contained gold (koz) Contained copper (Mt) Contained antimony (kt)
Björkdal 22,474 2.07     1,497    
Tomingley 17,302 2.1     1,184    
Costerfield 1,993 6.0   2.1 387   42.0
Boda Kaiser2 537,000 0.32 0.19   5,573 1.01  
TOTAL 578,796 0.46     8,641 1.01 42.0
               

Group Inferred Mineral Resources

Location Tonnage (kt) Gold grade (g/t) Copper grade (%) Antimony grade (%) Contained gold (koz) Contained copper (Mt) Contained antimony (kt)
Björkdal 12,096 1.57     611    
Tomingley3 4,549 2.1     304    
Costerfield 969 3.6   1.3 111   12.9
Boda Kaiser 258,000 0.33 0.18   2,731 0.45  
TOTAL 275,614 0.42     3,757 0.45 12.9
               

Group Ore Reserves

Location Tonnage (kt) Gold grade (g/t) Antimony grade (%) Contained gold (koz) Contained antimony (kt)  
Björkdal 13,121 1.33   563    
Tomingley 11,407 1.7   641    
Costerfield 960 5.5 1.6 170 15.0  
TOTAL 25,488 1.7   1,374 15.0  
             

Alkane Managing Director & CEO, Nic Earner, said:

“We are pleased to report continued growth in resources at each producing asset, with all assets replacing depletion through continued exploration and extension of mineral resources. This growth reflects the success of our exploration programs and reinforces the value and potential we see in Alkane’s producing portfolio.”

Competent Persons

The information in this report that relates to the Björkdal, Tomingley and Costerfield Mineral Resource and Ore Reserve Statements and is based on the ‘Björkdal Resources and Reserves Statement FY26’, ‘Tomingley Resource and Reserve Statement FY26’ and ‘Costerfield Resources and Reserves Statement FY26’ all dated 11 September 2026. Those documents have been approved by Mr Chris Davis. Mr Davis is a Chartered Professional (Geology) of the Australasian Institute of Mining and Metallurgy (MAusIMM CP(Geo)), and a Member of the Australian Institute of Geoscientists (MAIG).

Mr Davis has sufficient experience that is relevant to the style of mineralisation and type of deposit under consideration and to the activity being undertaken to qualify as a Competent Person as defined in the 2012 Edition of the “Australian Code for Reporting of Exploration Results, Mineral Resources, and Ore Reserves” (JORC Code).

For the purposes of National Instrument 43-101 – Standards of Disclosure for Mineral Projects (‘NI 43-101’), the scientific and technical information contained in this announcement relating to the Storheden Results has been prepared under the supervision of, and approved by, Mr Chris Davis, who is a “qualified person” as defined in NI 43-101. Mr Davis is employed by Alkane as Chief Geologist and, as an employee of Alkane, is not considered independent of Alkane within the meaning of NI 43-101.

Mr Davis consents to the inclusion in this report of the matters based on his information in the form and context in which they appear.

Investors outside Australia should note that while Ore Reserve and Mineral Resource estimates of the Company in this announcement comply with the JORC Code 2012, they may not comply with the relevant guidelines in other countries.

Technical Reports released to the TSX or for TSX Market

Alkane has prepared the following NI 43-101 compliant technical reports which support the information contained herein, each of which is available under Alkane’s profile on SEDAR+ at www.sedarplus.ca:

  • ‘Boda-Kaiser Copper-Gold Project, New South Wales, Australia’ with an effective date of 6 June 2025;
  • ‘Tomingley and Peak Hill Gold Projects, NSW, Australia’ dated 11 September 2026 with an effective date of 30 June 2026.
  • ‘Costerfield NI 43-101 Technical Report’ dated 11 September 2026 with an effective date of 30 June 2026; and
  • ‘NI 43-101 Technical Report, Björkdal Gold Mine, Sweden’ dated 11 September 2026, with an effective date of 30 June 2026.

Reference should be made to the full text of the foregoing technical reports for the assumptions, qualifications and limitations relating to the Mineral Resource Estimates and Ore Reserves contained therein and herein. All material assumptions and technical parameters underpinning the estimates in the technical reports continue to apply and have not materially changed.

This document has been authorised for release to the market by Nic Earner, Managing Director & CEO.

ABOUT ALKANE ‐ alkres.com ‐ ASX:ALK | TSX: ALK | OTCQX: ALKRY
Alkane Resources (ASX:ALK; TSX:ALK; OTCQX:ALKRY) is an Australia-based gold and antimony producer with a portfolio of three operating mines across Australia and Sweden. The Company has a strong balance sheet and is positioned for further growth.

Alkane’s wholly owned producing assets are the Tomingley open pit and underground gold mine southwest of Dubbo in Central West New South Wales, the Costerfield gold and antimony underground mining operation northeast of Heathcote in Central Victoria, and the Björkdal underground gold mine northwest of Skellefteå in Sweden (approximately 750km north of Stockholm). Ongoing near-mine regional exploration continues to grow resources at all three operations.

Alkane also owns the very large gold-copper porphyry Boda-Kaiser Project in Central West New South Wales and has outlined an economic development pathway in a Scoping Study. The Company has ongoing exploration within the surrounding Northern Molong Porphyry Project and is confident of further enhancing eastern Australia’s reputation as a significant gold, copper and antimony production region.

Interactive Analyst Centre™ 
Comprehensive financial, operational, resource and reserve information for Alkane Resources is available through the Interactive Analyst Centre™ located in the Investors section of our website at alkres.com.

Cautionary Note Regarding Forward-Looking Information and Statements
This announcement contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation and may include future-oriented financial information or financial outlook information (collectively “Forward-Looking Information”). Actual results and outcomes may vary materially from the amounts set out in any Forward-Looking Information. As well, Forward-Looking Information may relate to: future outlook and anticipated events; expectations regarding exploration potential; production capabilities and future financial or operating performance, including AISC, investment returns, margins and share price performance; production and cost guidance and the timing thereof; issuing updated resources and reserves estimate and the timing thereof; the potential of the Company to meet industry targets, public profile and expectations; and future plans, projections, objectives, estimates and forecasts and the timing related thereto. Forward-Looking Information is generally identified by the use of words like “will”, “create”, “enhance”, “improve”, “potential”, “expect”, “upside”, “growth” and similar expressions and phrases or statements that certain actions, events or results “may”, “could”, or “should”, or the negative connotation of such terms, are intended to identify Forward-Looking Information. Although Alkane believes that the expectations reflected in the Forward-Looking Information are reasonable, undue reliance should not be placed on Forward-Looking Information since no assurance can be provided that such expectations will prove to be correct. Forward-Looking Information is based on information available at the time those statements are made and/or good faith belief of the officers and directors of Alkane as of that time with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or suggested by the Forward-Looking Information. Forward-Looking Information involves numerous risks and uncertainties. Such factors include, without limitation: risks relating to changes in the gold and antimony price. Forward-Looking Information is designed to help readers understand Alkane’s views as of that time with respect to future events and speak only as of the date they are made. Except as required by applicable law, Alkane assumes no obligation to update or to publicly announce the results of any change to any forward-looking statement contained or incorporated by reference herein to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the Forward-looking Information. If Alkane updates any one or more forward-looking statements, no inference should be drawn that the company will make additional updates with respect to those or other Forward-looking Information. All Forward-Looking Information contained in this announcement is expressly qualified in its entirety by this cautionary statement.

Disclaimer
Alkane has prepared this announcement based on information available to it. No representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information, opinions or conclusions contained in this announcement. To the maximum extent permitted by law, none of Alkane, its directors, officers, employees, associates, advisers and agents, nor any other person accepts any liability, including, without limitation, any liability arising from fault or negligence on the part of any of them or any other person, for any loss arising from the use of this announcement or its contents or otherwise arising in connection with it. This announcement is not an offer, invitation, solicitation, or other recommendation with respect to the subscription for, purchase or sale of any security, and neither this announcement nor anything in it shall form the basis of any contract or commitment whatsoever. 

___________________________
1  Refer to ALK announcements titled ‘Tomingley Resources and Reserves Statement FY26’, ‘Costerfield Resources and Reserves Statement FY26’ and ‘Björkdal Resources and Reserves Statement FY26’ dated 11 September 2026 for complete details for each estimate
2  Boda Kaiser has net been re-estimated and remains as described in ASX Announcement – 15 October 2025 “NSW Resource and Reserve Statement FY25”
3  Includes Peak Hill Mineral Resource

CONTACT:  NIC EARNER, MANAGING DIRECTOR & CEO, ALKANE RESOURCES LTD, TEL +61 8 9227 5677
INVESTORS & MEDIA:  NATALIE CHAPMAN, CORPORATE COMMUNICATIONS MANAGER, TEL +61 418 642 556

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.